Live Breaking News & Updates on Immunotherapies Saits

Stay updated with breaking news from Immunotherapies saits. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

GlobeNewswire

December 22, 2021

Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater China Collaboration accelerates the global development of AFFiRiS potential first-in-class active immunotherapy with plans to. ....

United States , Hong Kong , Immunotherapies Saits , Richard Zhao , Donald Xu , Noel Barrett , Changjin Wang , Business Development Strategy , Frontier Biotechnologies Inc , Frontier Biotechnologies , Greater China , Lynx Financial , Managing Partner , European Journal , Clinical Pharmacology , Frontier Biotech , Business Development ,

DGAP-News: AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology

DGAP-News: AFFiRiS AG / Key word(s): Study results AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology 27.05.2021 / 11:00 The issuer is solely responsible for the content of this announcem. ....

Immunotherapies Saits , Julia Hofmann , Markus Zeitlinger , Cornelia Kutzer , Noel Barrett , Mc Services , University Of Vienna , Distribution Services , Business Development , European Journal , Clinical Pharmacology , Associate Professor , Medical University , Chief Technology Officer , Corporate News , Regulatory Announcements , Dgap News , ஜூலியா ஹாஃப்மேன் , நோயல் பாரெட் , ம்ஸீ சேவைகள் , பல்கலைக்கழகம் ஆஃப் வியன்னா , விநியோகம் சேவைகள் , வணிக வளர்ச்சி , ஐரோப்பிய இதழ் , மருத்துவ மருந்தியல் , இணை ப்ரொஃபெஸர் ,

DGAP-News: AFFiRiS AG: AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of Clinical Pharmacology

DGAP-News: AFFiRiS AG / Key word(s): Study results AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9 to treat hypercholesterolemia published by the European Journal of ....

Immunotherapies Saits , Julia Hofmann , Kostenloser Wertpapierhandel , Markus Zeitlinger , Cornelia Kutzer , Noel Barrett , Mc Services , University Of Vienna , Distribution Services , Business Development , European Journal , Clinical Pharmacology , Associate Professor , Medical University , Chief Technology Officer , Corporate News , Regulatory Announcements , ஜூலியா ஹாஃப்மேன் , நோயல் பாரெட் , ம்ஸீ சேவைகள் , பல்கலைக்கழகம் ஆஃப் வியன்னா , விநியோகம் சேவைகள் , வணிக வளர்ச்சி , ஐரோப்பிய இதழ் , மருத்துவ மருந்தியல் , இணை ப்ரொஃபெஸர் ,